Genetics & ageing
Prof. Jan Vijg
Chairman of Genetics, Albert Einstein College of Medicine
Our partnersEST. 2009
The names that stand behind the medicine.
We work with leading professors, clinicians, scientists and research institutions worldwide to advance integrative and regenerative medicine: co-developing protocols, accommodating referred patients, and exploring the frontiers of care.
Credibility, on the record
- 18advisory professors
- 12research institutions
- 35+alliance partnerships
01 — Medical & scientific advisory board
The minds behind the medicine.
Our advisory board brings together leading professors and clinicians in longevity, oncology, neurology, cellular medicine and genetics. Their credibility and clinical insight keep Verita at the cutting edge of treatment.
Board leadership
Prof. Dr. Alexander Haslberger
Professor, University of Vienna
Prof. Dr. Bernd Kleine-Gunk
President, German Society of Anti-Aging Medicine
Dr. Ferran Guedea
Director of Radiation Oncology, ICO Barcelona; Professor, University of Barcelona
The full board
18 professors & clinicians · six disciplinesCellular, genetics & longevity08
Neurophysiology & stem cells
Prof. Jürgen Hescheler
Director, Institute of Neurophysiology; President, German Society for Stem Cell Research
Cardiovascular prevention
Prof. Dr. Uwe Nixdorff
Associate Professor, University Clinic Erlangen; Founder, European Prevention Center
ENT & anti-ageing
Dr. Michael Zacharia
President, Australasian Academy of Anti-Ageing Medicine
Cellular & stem-cell science
Prof. Kuldip S Sidhu
UNSW Medicine; CSO, CK Cell Technologies
Cellular research
Dr. Veerapol Khemarangsan
CEO, Bangkok Stem Cells
Preventative medicine
Prof. Eugen Molodysky
Former President, Australasian College of Nutritional & Environmental Medicine
Cell therapy & ATMP
Dr. Agne Vaitieviene
CEO, Memel Biotech; Vice President, LithuaniaBIO
Disease prevention, oncology & neurology08
Integrative oncology
Dr. Ursula Jacob
Specialist in Oncology, Immunotherapy & Integrative Medicine
Functional neurosurgery
Dr. Rodrigo Mercado Pimentel
Verita Neuro Medical Director, Mexico
Endocrinology
Prof. Dr. Johannes Huber
Head, Gynaecological Endocrinology & Reproductive Medicine, University of Vienna
Microbiology & immunology
Prof. Claudia Gravekamp
Associate Professor, Albert Einstein College of Medicine
Neurosurgical oncology
Prof. Dr. Guilherme Lepski
Head of Neurosurgical Oncology, University of São Paulo
Urology & oncology
Prof. Dr. Shahrokh F. Shariat
Professor & Chairman of Urology, University of Vienna
Healthcare transformation
Dr. Hala Baht
Healthcare Transformation Specialist, GCC markets
02 — Research & institutional partners
The institutions that hold the work to account.
Our research engine is powered by collaborations with leading universities, academies and institutes. Together we co-author studies and advance protocols in cellular therapy, diagnostics, longevity science and neurology.
01Austria
University of Vienna
Epigenetics · endocrinology · urology
02United Kingdom
Imperial College London
Clinical research
03United States
Albert Einstein College of Medicine
Genetics · immunology
04Brazil
University of São Paulo
Neurosurgical oncology
05Canada
University of Calgary
Neurology · rehabilitation
06Canada
Synaptic, Toronto
Neuromodulation research
07Germany
German Society of Anti-Aging Medicine
Longevity · GSAAM
08Australia
Australasian Academy of Anti-Ageing Medicine
Anti-ageing · AAAM
09Japan
Timo, Japan
Immune cell research
10Lithuania
Froceth Institute
Immune cell research
11Lithuania
Memel Biotech
Cell therapy · ATMP
12Australia
CK Cell Technologies (UNSW)
Cellular medicine
Verita co-authors peer-reviewed studies with these institutions. Explore the published record on Science →
03 — Investors & strategic partners
Backed for the long term.
Verita is supported by committed investors, strategic alliance partners and a board with decades of experience scaling healthcare and consumer businesses worldwide.
Maelstrom Fund
Growth investor backing the 2025 restructure of the group under Verita Healthcare, supporting the next phase of clinic and product expansion.
Growth investmentMinor Hotel Group
Hospitality alliance bringing Verita wellness and longevity clinics into Anantara properties across Thailand, beginning with Anantara Siam, Bangkok.
Hospitality allianceHanako GmbH
Digital health investment partner advancing the technology and data platforms that connect diagnostics, protocols and patient care across the group.
Digital health04 — The Verita Alliance
A network you can join.
An alliance partnership is a formal clinical relationship. Partner clinics and hospitals license Verita’s proprietary protocols, products and standards of care, and their patients gain access to our global network and specialists. We hold 35+ such partnerships across Australia, Southeast Asia and Europe.
01Medical clinics & hospitalsJoin 35+ alliance clinics and hospitals worldwide. Partners gain access to Verita’s proprietary treatment protocols, products and services through the Verita Alliance Programme.Become an alliance partner02Doctors & specialistsWe accept referrals in preventative and anti-aging medicine, integrative oncology, and neurological care. Our process is transparent and consultative, with patient preferences informing every decision.Refer a patient03Product distributors & suppliersVerita distributes nutraceuticals, supplements, peptides, hormones, IV therapies and advanced biologics. We welcome enquiries from global distribution partners and suppliers.Partner with us
Let’s build the network, together.
Whether you lead a clinic, refer patients, distribute products or invest in healthcare, our partnerships team would like to hear from you.